×

RNS Number : 6441U

BMR Mining PLC

31 July 2015

 

BMR Mining PLC

("BMR" or the "Company")

Significant Testing Progress Update

 

BMR Mining PLC, the Zambian-focused mineral processing business, is pleased to announce significant progress on its testing results.

 

Highlights:

 

–       Wash Plant Tailings demonstrate materially increased lead and zinc recoveries during additional laboratory optimisation testing;

 

–       successful recovery of lead and zinc products by precipitation and electro winning from the pregnant liquor solution;

 

–       potential recovery of 77% of zinc from Imperial Smelting furnace slag, a resource that was previously written off;

 

–       recognising positive metallurgical work undertaken, the Company intends to commence pilot processing plant operations this financial year.

 

Alex Borrelli, CEO and Chairman, commented:

"We are delighted to have achieved positive progress across our recent metallurgical testing which could significantly enhance the inherent value of the Company's commercial interests going forward.  While shareholders should be aware that the results of the laboratory tests may not be matched by commercial processing, we are confident that the processes are scalable and we will move quickly through to the pilot plant stage of evaluation.

"As shareholders will likely appreciate there is still further work to undertake but receiving this positive data at this stage makes a tremendous difference and greatly encourages the BMR team.

"We are enthusiastically pushing forward and further operational news updates will follow in the near term as the Company continues its work."

 

Wash Plant Tailings

The Company is pleased to announce that, following further laboratory testing, our optimisation of the proposed acid/brine leach process has resulted in the possibility of achieving higher metal recoveries from the Wash Plant Tailings (WPT) than previously reported.

The WPT was estimated by Mineral Corporation Consultancy (Pty), in its March 2012 report, to contain 573,458 dry tonnes (JORC compliant) at a mean grade of 10.66% Zn and 7.21% Pb (61.4kt contained Zn and 41.3kt contained Pb).

The potential lead and zinc recoveries that have been achieved into a Pregnant Liquor Solution (PLS) are 94.2% Pb and 79.6% Zn. These higher recoveries compare favourably with the earlier test results announced of 80% Pb and 70% Zn for the WPT and proving the commercial viability of scaling this new process will be the next stage of our evaluation.

This test work was carried out in conjunction with the Company's Mineral Processing Partner in its metallurgical test laboratory and was witnessed by Jeremy Hawke, Director, and Dr Geoff Casson, General Manager, Kabwe.

 

Final Products

The Company also announces the successful recovery in testing by precipitation and electro winning from the PLS of the following products:

·      a lead sponge with a grade of 96% Pb

·      a rough zinc cathode with a grade of 98.72% Zn

·      a refined zinc cathode with a grade of 99.6% Zn

 

Imperial Smelting Furnace Slag (ISF Slag)

The Company was advised last year that the effective economic recovery of zinc from the ISF slag would prove difficult, being brittle and hard to process, and consequently the value of this resource was written off in the 2014 Annual Report.

The ISF slag had been estimated by Mineral Corporation Consultancy (Pty), in its March 2012 report to contain 1,481,563 dry tonnes (non-JORC) at a mean grade of 8.07% Zn (119.6kt contained Zn). 

As the ISF slag comprises a significant unexploited zinc resource, the Directors decided to re-examine the potential for the recovery of zinc from this source and we have been working closely with our consultants in order to assess commercial feasibility. Following recent mineralogical and exploratory metallurgical test work the Company is pleased to announce that, in conjunction with its Mineral Processing Partner, a recovery of 77.2% Zn has been successfully achieved in laboratory analysis. This metallurgical test work was also witnessed by Jeremy Hawke and Dr Geoff Casson.

Further work will now be undertaken to optimise this recovery and to establish if it can also be processed by the proposed flow sheet for the other Kabwe tailings and residues. In the event that this further work concludes positively, the Company will commission a JORC compliant survey of the ISF slag.

 

Pilot Plant Processes and Intellectual Property

The metallurgical processes that have been developed to achieve the recoveries and final products above are proprietary to BMR and your Directors are taking the appropriate steps to protect this intellectual property.  These processes are being incorporated into the design of the Kabwe pilot plant.

Subject to the approval of the Zambian Environmental Management Agency ("ZEMA") when finalised plans are submitted within the next four weeks, the Company intends to commence pilot plant operations in this financial year. It is also the intention of the Company to process first the higher-grade, higher-recovery WPT to generate initial returns from the Company's asset base.

Note:

This release has been reviewed by Geoff Casson, B.Sc. (Hons), PhD, R Eng (Zambia), Member Engineering Institute of Zambia (Metallurgy), General Manager of the Company's Zambian subsidiary, Enviro Processing Ltd, who is a Qualified Person in accordance with the guidance note for Mining, Oil & Gas Companies issued by the London Stock Exchange in respect of AIM Companies.

 

Ends

 

 

For further information:

BMR Mining PLC                                                                                                        020 7734 6252

Alex Borrelli, CEO and Chairman

 

WH Ireland Limited                                                                                                   020 7220 1666

Chris Fielding, Head of Corporate Finance

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCEAKXEDSNSEFF

Close

×

RNS Number : 8362T

Midatech Pharma PLC

23 July 2015

 

23 July 2015

 

Midatech Pharma PLC

("Midatech" or the "Company")

 

Initiation of Phase IIa study of insulin delivery via buccal strip for type 1 diabetes

 

Midatech (AIM: MTPH), the international specialty pharmaceutical company with a diversified portfolio of high-value products in development, in partnership with MonoSol Rx, today announces that the first patient has been treated in a Phase IIa open label, cross-over, seven arm study of Insulin Buccal Soluble Film (MSL-001) for type 1 diabetes mellitus.

 

The objectives of the study are to establish the pharmacodynamic and pharmacokinetic profile, and safety and tolerability of MSL-001 (MidaForm® Insulin PharmFilm®) in comparison to subcutaneous administered human recombinant insulin (Humulin®).

 

The study is being conducted in Perth, Australia, with a total of 12 patients, male and female, aged 18 – 55 being treated from a screening pool of up to 35 subjects. The overall study duration is approximately five months.

 

MSL-001 contains recombinant human insulin which is non-covalently bound to glycan-coated gold nanoparticles and embedded in an oral, muco-adhesive, polymeric film for transbuccal delivery.  The drug was invented by Midatech and MonoSol Rx and is being developed by the parties' joint venture, MidaSol Therapeutics.

 

Commenting on the study, Dr. Jim Philips, CEO of Midatech Pharma, said: "Diabetes incidence is forecast to hit 500m people, globally, by 2025; with our partnered transbuccal insulin strip, MSL-001 is targeting a $20 billion market, adding significant revenue potential to our growing portfolio of products."

 

– Ends –

 

For more information, please contact:

 

Midatech Pharma PLC

Jim Phillips, CEO

Tel: +44 (0)1235 841575

www.midatechpharma.com

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)

Corporate Finance

Freddy Crossley / Adam James / Atholl Tweedie / Duncan Monteith

 

 

Broking

Tom Salvesen

Tel: +44 (0)20 7886 2500

 

Consilium Strategic Communications (Financial PR)

Mary Jane Elliott / Ivar Milligan / Matthew Neal / Hendrik Thys

Tel: +44 (0)20 3709 5700

Email: midatech@consilium-comms.com

 

 

About Midatech Pharma PLC

 

Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. These diseases include diabetes, rare cancers including brain (glioblastoma), ovarian, liver and pancreatic cancer and neurological/ophthalmologic conditions.  Midatech's strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.

 

Midatech's core product candidates derive from its two multi-applicable platform technologies that can be used alone or in combination to enable the targeted delivery ('right place') and controlled release ('right time') of existing drugs. These technologies are provided through its wholly-owned subsidiaries, Midatech and Q-Chip (acquired in 2014).  Midatech's core platform is a drug conjugate delivery system based on a patented form of gold nanoparticles (GNP) combined with existing drugs for the safe and targeted release of therapeutic payloads at specific organs, cells or sites of disease.

The Group's second platform is a sustained release technology acquired with Q Chip that involves the consistent and precise encapsulation of active drug compounds within polymer microspheres enabling their release into the body in a highly controlled manner over a prolonged period of time.

On 4 June 2015, Midatech announced a proposed acquisition of DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company, based in Raleigh, NC. The acquisition brings a portfolio of marketed oncology products and a salesforce in US to Midatech and is expected to complete in H2 2015.

The Group is headquartered near Oxford, UK, with a nanoparticle manufacturing operation in Bilbao, Spain and an R&D facility in Cardiff, UK.  For further company information see: www.midatechgroup.com.

 

 

About MonoSol Rx

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to develop products which address the unmet needs of patients.  PharmFilm® is designed to benefit patients by improving the safety, efficacy, compliance and convenience of new and currently marketed drugs.  The Company's leadership in film drug delivery is supported by strong intellectual property, a pipeline of prescription formulations based on PharmFilm® technology, and two FDA approvals – Zuplenz®, the first approved prescription oral soluble film for the prevention of chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting, and Suboxone® sublingual film, the first sublingual film product for the treatment of opioid dependence.  For press releases and other company information visit: www.monosolrx.com.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCPGUPPMUPAUAW

Close

×

RNS Number : 4352T

Proton Power Systems PLC

20 July 2015

 

 

 

 

Proton Power Systems plc

 

("Proton" or the "Company")

 

 

Cooperation Agreement with German Rail subsidiary Bahnbau 

for sales and service of hydrogen fuel cell UPS systems

 

Proton Power Systems plc (AIM: PPS), the designer, developer and producer of fuel cells and fuel cell electric hybrid systems, is pleased to announce, that it signed a cooperation agreement with DB Bahnbau Gruppe GmbH ("Bahnbau"), the service company of German Rail ("DB") for rail network infrastructure installation and maintenance. Bahnbau will sell and install Proton's containerised fuel cell systems as UPS applications to DB and third party customers. DB is planning to replace the installed base of diesel generator UPS systems with zero emission fuel cell applications over the coming years.

 

Bahnbau will provide the site planning, installation and service for containerised systems from Proton. In addition to DB, Bahnbau will also offer those solutions to other third party customers in industries like IT, transport and manufacturing. Bahnbau (www.bahnbaugruppe.de) has one of the largest technical service organisations in Germany.

 

The decision to replace old diesel systems is not only based on environmental aspects but also on commercial aspects. High maintenance cost for old diesel installations makes it more commercially viable for DB installations to use the new fuel cell technology. Proton will supply complete containerised solutions with the fuel cell, switchgear, cooling and UPS system for a power demand from 6 to 250kW.

 

Faiz Francoise Nahab, CEO of Proton, said: "This is a key milestone for our company and fits well within the recent expansion of our manufacturing facilities enabling large quantity manufacturing capacity. To work with experts like Bahnbau is something we always had in mind. The decision of DB to use fuel cell UPS systems to replace old diesel applications is also to be seen as a milestone for our industry. Not only has the environmental aspect driven that decision but also commercial considerations, which is very important for our industry."

 

– Ends –

 

 

 

 

For further information:

Proton Power Systems plc
Dr Faiz Nahab, CEO
Achim Loecher, FD Ian Peden, Chairman	Tel: +49 (0) 89 127 626 550 Tel: +49 (0) 162 101 6470
	www.protonpowersystems.com

 

Westhouse Securities Limited Nominated adviser and broker	Tel: +44 (0) 20 7601 6100
Antonio Bossi / David Coaten	www.westhousesecurities.com

 

 

About Proton Motor Fuel Cell GmbH

Proton Motor is an expert in industrial fuel cells, fuel cell and hybrid systems with more than 17 years of experience in this sector.  Based in Puchheim near Munich, Proton Motor offers complete fuel cell and hybrid systems from a single source – from the development and production through the implementation of customized solutions.  The focus of Proton Motor is on back-to-base, for example, for mobile, marine and stationary solutions applications.  The product portfolio consists of base-fuel cell systems, standard complete systems, as well as customized systems.

 

Proton Motor acquired SPower GmbH in 2013. Established in 2007, SPower serves IT, Telecoms, public infrastructure and healthcare customers in Germany, Europe and Middle East with power supply solutions for DC and AC power demand. In addition to power supply, SPower also offers solutions for Solar Systems as well as a new product line for Solar Energy Storage.

 

Proton Motor Fuel Cells GmbH is wholly owned subsidiary of Proton Power Systems plc.  The Company has been listed on the London Stock Exchange since October 2006 (code: PPS).

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRPKODPPBKDDOD

Close

×

Orchard Funding Group is delighted to announce that its subsidiary Bexhill UK Limited has been granted full Financial Conduct Authority ("FCA") permission to conduct business as a consumer credit lender and credit broker. Orchard Funding Group is considered the first insurance premium finance lender and professional fee funder in the UK to obtain full FCA consumer lending permissions.

FCA permission follows on from the Company's recent flotation on the London Stock Exchange earlier this month and together they reflect the past success of the business and the growing reputation and potential of the Company going forward. Trust is a key component of doing business and for those companies from the insurance sector or the professions sector looking for a finance provider; the Directors believe that the FCA permission will be a key point of differentiation.

Orchard Funding Group is also delighted to announce that its subsidiary Bexhill UK Limited has become a consumer credit Principal – Appointed Representative, considered the first in the UK to obtain this status. This will enable credit brokers of unsecured credit to avoid the expense and burden of direct FCA regulation by becoming an Appointed Representative of Bexhill UK Limited. Bexhill UK Limited can now offer this facility to unsecured credit brokers in the UK and intends to market this service to enable them to take advantage of Bexhill's Appointed Representative Network.

Ravi Takhar, Chief Executive Officer of Orchard Funding Group stated, "We are very pleased to receive the great news of Bexhill UK's obtaining full FCA permission for consumer credit lending and consumer credit brokerage. We are also delighted to become one of the first consumer credit Principal-Appointed Representative in the UK and hope to provide assistance to consumer credit brokers by helping with the burden of FCA regulation. July has been a great for us with the combination of achieving both a London Stock Exchange listing and full FCA permission – it could not have been a better month."

 

For further information please contact

Orchard Funding Group PLC                                                                   +44 (0)1582 635 507

Ravi Takhar, Chief Executive Officer

 

Panmure Gordon Limited (Nomad and Broker)                                      +44 (0)20 7886 2500

Dominic Morley (Corporate Finance)

Adam James (Corporate Finance)

Alina Vaskina (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)

 

Novella                                                                                                        +44 (0)20 3151 7008

Tim Robertson

Ben Heath

               

For Investor Relations please go to: www.orchardfundinggroupplc.com

 

Close

×

·     Avanti awarded contract with RSA business chamber for wide scale SME connectivity

·     South African Government funding for Ka-band satellite broadband to over 1,000 SMEs

Avanti Communications Group plc ("Avanti" or "the Group"), a leading provider of satellite data communications services in Europe, the Middle East and Africa, has signed a new contract with South Africa's business chamber, Foundation for African Business and Consumer Services (FABCOS) and its new major business incubator programme, Microtelco e-ncubator™.

Delivered via funding from South Africa's Department of Trade and Industry (DTI), the partnership will provide high speed satellite broadband to over 1,000 small and medium sized enterprises. The programme will be deployed extensively to businesses setting up in some of the remotest parts of South Africa, reaching a number of key sectors including retail, finance and agriculture.

Delivery of resilient broadband connectivity underpins the RSA government's business growth strategy. Research demonstrates that SMEs are the building blocks of an economy: 91% of the entities in South Africa are SMEs, of which 52-57% contribute to the country's GDP. FABCOS's Microtelco e-ncubator™ programme specifically nurtures small telecommunications companies, for which connectivity is a vital part of day to day operations.

Alan Campbell, Director of ICTGLOBE Technology Encubator (Pty) Ltd and National Treasurer General at FABCOS: "Our new contract with Avanti is enabling us to deliver resilient broadband at scale to our vast membership. Access to broadband has become as important as any other utility for businesses here to succeed. Indeed, it is an integral part of our incubation offering to our members. A huge opportunity exists for connected enterprises in Africa, and we are excited for what lies ahead with this significant satellite partnership."

David Williams, Chief Executive of Avanti  commented: "Working hand-in-hand with FABCOS, its incubator and the South African government, this contract will deliver vital connectivity and training to the hundreds of businesses for whom broadband will power growth. FABCOS is acting today to bring the countless socio-economic benefits of broadband to its members.  Avanti shows that no-one in South Africa needs to wait for tomorrow to get connected."

For further information please contact:

Avanti: Matthew Springett, +44 (0)207 749 6703

Montfort: Nick Miles / James Olley, +44 (0)203 770 7909

Redleaf: Hannah Nicolas, +44 (0)207 382 4734

Cenkos Securities: Max Hartley (Nomad) / Julian Morse, +44 (0)207 397 8900

About Foundation for African Business and Consumer Services (FABCOS)

FABCOS promotes the development of township and rural small businesses by striving for the advancement of its members to help them secure economic empowerment, self-reliance, and respect.​ Through active participation in formal business and governmental initiatives, FABCOS campaigns for the continual improvement of South Africa's socio-economic climate for the benefit of its members. As a means of developing its members to their full potential FABCOS remains committed to the pursuit of education, training, transfer of skills and sound administration.

 Visit: www.fabcos.org 

About Microtelco e-ncubator™

The microtelco e-ncubator™ is a business initiative that offers a variety of programmes and services designed for the new, young and expanding telecommunications business. Beginning with your orientation to the e-ncubator™, we have designed our physical environment to provide you with access to a full spectrum of skills, resources and infrastructure that will make an effective contribution to the growth of your business and the enhancement of its image.

Our mission with the training, development and incubation programme is to stimulate the establishment and growth of small businesses and to increase the number of successful companies. We provide physical business facilities, executive development programmes, technical training, product specific-training business support services, mentoring and ongoing business monitoring and evaluation.

Visit: www.microtelcoencubator.com 

About Avanti Communications

Avanti connects people wherever they are – in their homes, businesses, in government and on mobiles. Through the HYLAS satellite fleet and more than 150 partners in 118 countries, the network provides ubiquitous internet service to 27 per cent of the world's population. Avanti delivers the level of quality and flexibility that the most demanding telecoms customers in the world seek.

Avanti is the first mover in high throughput satellite data communications in EMEA. It has rights to orbital slots and Ka-band spectrum that cover an end market of over 1.5bn people. The Group has invested $1.2bn in a network that incorporates satellites, ground stations, datacentres and a fibre ring. Avanti has a unique Cloud based flexible customer interface that is protected by patented technology. 

The Group has three satellites in orbit and a further two fully funded satellites under construction. Avanti Communications is listed in London on AIM (AVN:LSE). 

Visit: www.avantiplc.com

Close

×

LightwaveRF Plc ("LightwaveRF" or the "Company"), the creator of the LightwaveRF Smart Home Platform and products for the Internet of Things (IoT) enabling households and businesses to remotely operate and control lighting, power, heating and security using smartphones, tablets, PC and MAC applications, announces that further to the recent Heads of Terms, it has signed a long term supply contract with Havells India Limited.

A bespoke range of lighting, power and cooling control products will be developed and supplied alongside the existing core LightwaveRF range.  It is anticipated that in due course the range will be stocked in over 290 Havells' owned showrooms across India.

The products to be supplied to Havells are all based on core LightwaveRF technology, encompassing the Company's current device functionality and Apps.  The range will also see the addition of more functional air conditioning control to the LightwaveRF portfolio. 

Havells will fund $37,500 of development costs.  All the IP rights concerning technology will remain with LightwaveRF.  Havells shall retain all rights in the Customised Products and Havells will, assisted by LightwaveRF, obtain registration over these designs in India.  The contract requires 50% deposit with order and final payment ex-works.  Volumes are contracted to be a minimum of $500,000 in year 1 rising to $1,500,000 over 3 years.  The deal creates a two-way exclusive arrangement for the Indian market and addresses Havells' IoT strategy.

Commenting Mike Lord, Chairman and CEO, said "Havells is a major successful Brand in India and across the Globe.  We are delighted to be chosen as their Internet of Things smart home technology partner."

Havells' Head of Corporate Communications, Anil Sharma, commented "We have been very impressed with the LightwaveRF technology and have chosen this partnership after extensive research into competing technologies.  We look forward to a long and prosperous relationship with LightwaveRF."

Havells India Limited is a $1.4 Billion fast moving electrical goods company with a strong global footprint. Havells manufactures a wide spectrum of products, including industrial and domestic circuit protection devices, cables and wires, motors, pumps, fans, modular switches, home appliances, electric water heaters, power capacitors, CFL lamps, luminaires for domestic, commercial and industrial applications.

In 2007 Havells India acquired world renowned lighting company Sylvania, thus becoming one of the top four lighting companies in the world.

For further information:    

Contacts:
LightwaveRF Plc	www.lightwaveRF.com
Mike Lord, CEO Tom Sykes, CFO	+44 (0)  121 250 3625
WH Ireland Limited	www.wh-ireland.co.uk
Mike Coe/Ed Allsopp (Corporate Finance)	+44 (0) 117 945 3470
Jasper Berry (Institutional Sales)	+44 (0) 20 7220 1666

Close

×

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that it has received its first product registration in Brazil from the Brazilian Ministry of Agriculture. With this registration, the Company and its partners will be allowed to sell products based on its current generation of commercialized protein technology for foliar use on all crops.

Plant Health Care's protein technology is now approved for usage in 12 countries, including Brazil and the United States, which represent the two largest agricultural markets in the world. In addition, this registration allows the Company to move forward with the development and distribution agreement it signed with Arysta LifeScience in December, 2014 for foliar application of its technology to sugarcane in Brazil. Under that contract, Arysta LifeScience agreed to evaluate the Company's current protein technology across a range of geographical locations throughout Brazil and generate detailed information on increased biomass and sucrose production. In earlier studies, the technology showed significant and reliable increases in sugarcane yield. Pending consistent and reliable test results in the evaluation program, first sales of the product in Brazil are anticipated in the 2017 crop season.

Paul Schmidt, CEO of Plant Health Care, commented, "This registration is very significant to Plant Health Care as Brazil is the single largest agricultural market in the world. Sugarcane is one of the country's most important crops, covering more than 20 million acres, and a feedstock for the production of ethanol, which is a major component of Brazil's renewable fuel policy. Arysta LifeScience is a strong partner for the sugarcane market and we see the potential to establish a formidable position in this important sector."

João Marcos Ferrari, President & CEO of Arysta LifeSciences Do Brasil, commented, "We are excited to move forward with Plant Health Care in this collaborative effort. We have seen this technology provide significant increases in yield and sugar production in sugarcane and believe it will offer substantial benefits to growers. This is another important step toward our goal to be a leader in the applications of biological products in agricultural production."

The Company will issue interim results for the six months to June 30, 2015 on September 14, 2015.

– ENDS –

 

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer                                                      Tel: +1 (919) 926 1600

 

Liberum Capital – Nomad and Broker

Clayton Bush                                                                                       Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening                                                                Tel: +1 (212) 838 3777

Company website: www.planthealthcare.com

About Plant Health Care:  Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets.  In this way, Plant Health Care is capitalising on long-term trends toward natural systems and biological products for plant care and soil and water management.  The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC). 

About Arysta LifeScience:  Arysta LifeScience, now owned by Platform Specialty Products, is a leading crop protection and life science company with 2014 revenues of US$2.2 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products that meet the needs of its global partners. 

Close

×

·     Avanti appointed to supply major broadcast deployment for Aragon Government

·     Quantis deploys Avanti's HYLAS 1  technology to transmit HD content to 1.3m viewers

Avanti Communications Group plc ("Avanti" or "the Group"), a leading provider of satellite data communications services in Europe, the Middle East and Africa, has been appointed by Quantis to supply a major broadcast deployment for the Aragon Government in Spain.  The multi-year contract builds on Avanti's existing partnership with Quantis, through which Avanti delivers high speed broadband via satellite to Quantis' significant consumer and enterprise customer base.

The Government of Aragon will work with Quantis locally to broadcast signal for TV and radio channels including: Aragon, Aragon 2 HD, Aragón Radio, Aragón FM Radio 2 and TEA. Distribution will be deployed via Avanti's HYLAS 1 satellite to over 300 terrestrial repeaters, reaching 1.3m viewers in Aragon. 

Aquilino Antuña, CEO of Quantis, commented: "With this agreement we strengthen our position in the broadcast market. We consider it strategically important to the growth of our company. We are delighted to grow our contract with Avanti with this exciting proposition for over one million citizens in Aragon."

David Williams, Chief Executive of Avanti, commented: "This new contract will deliver a uniquely innovative broadcasting service for the Aragon government. In delivering this at scale, Avanti continues to extend the power of its distribution platform. We are now partner to some the world's largest broadcasters, providing services with unparalleled levels of quality and flexibility."

For further information please contact:

Avanti: Matthew Springett, +44 (0)207 749 6703

Montfort: Nick Miles / James Olley, +44 (0)203 770 7909

Redleaf: Hannah Nicolas, +44 (0)207 382 4734

Cenkos Securities: Max Hartley (Nomad) / Julian Morse, +44 (0)207 397 8900

 

Notes to editors

About Quantis

Quantis is the new generation satellite broadband operator in Europe. It is the largest supplier of satellite broadband services in Spain. With 100% availability all over the Iberian Peninsula, Canary and Balearic Islands as well as the rest of Europe and the North of Africa, Quantis provides customers with speeds of 20Mbps regardless of location.

Visit: www.quantis.es 

About Avanti Communications 

Avanti connects people wherever they are – in their homes, businesses, in government and on mobiles. Through the HYLAS satellite fleet and more than 150 partners in 118 countries, the network provides ubiquitous internet service to 27 per cent of the world's population. Avanti delivers the level of quality and flexibility that the most demanding telecoms customers in the world seek.

Avanti is the first mover in high throughput satellite data communications in EMEA. It has rights to orbital slots and Ka-band spectrum that cover an end market of over 1.5bn people. The Group has invested $1.2bn in a network that incorporates satellites, ground stations, datacentres and a fibre ring. Avanti has a unique Cloud based flexible customer interface that is protected by patented technology.

The Group has three satellites in orbit and a further two fully funded satellites under construction. Avanti Communications is listed in London on AIM (AVN:LSE). 

Visit: www.avantiplc.com

Close

×

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce that it has won its first order in a new EEC-member state Iceland, with an entity entering into a contract for the Company's CTM™ platform for more than two years, with implementation due to be completed during the third quarter of 2015.

In addition, in Denmark, EU Supply has entered into a four-year agreement with the last of the country's five regional governments. This means that all of Denmark's regional governments are using or will soon start to use EU Supply's CTM™ platform for their procurement. The implementation for the last regional government is also due to be completed during the third quarter of 2015.

In addition, Tender Lite is now being used by authorities and lead parties of consortia in a total of more than 40 authorities across Europe.

FURTHER ENQUIRIES

EU Supply PLC                            Tel: 020 7127 4545     Thomas Beergrehn, CEO   Mattias Ström, CFO   Westhouse Securities Tel: 020 7601 6100 Tom Griffiths, David Coaten

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for e-sourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 7,000 European public sector bodies in 10 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013 when the Company raised £5.0 million before expenses. In July 2014, the Company raised a further £1.35 million by way of a placing of new ordinary shares, the proceeds of which were mainly used to strengthen the Company's balance sheet, provide working capital to support the growth of the business as it expands and aims to gain market share and to provide additional funds for sales and marketing.

Close

×

Neville Registrars are delighted to welcome OXACO Plc as the newest addition to its list of client companies.

Oxaco Plc is an AIM quoted company focusing on development of materials science technologies. It holds a stake in Oxford Advanced Surfaces Limited. Founded in June 2006 by Professor Mark Moloney and Dr. Jon-Paul Griffiths, Oxford Advanced Surfaces was "spun-out" by Ora Capital, IP Group and OSEM from the Chemistry department at the University of Oxford, one of the largest chemistry research laboratories in the world. The initial development of the Onto™ technology began over a decade ago at the University and it has continued and expanded through OAS.

Further information can be found on the Company's website: http://www.oxaco.co.uk/

Close